Regulatory PathRegulatory requirements compared

Active substance

Normal human immunoglobulin

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
FLEBOGAMMA 5% DIF SOLUTION FOR INFUSION5 %Solution for infusion · Intravenous use1 VialSAR 224.15Biological · PrescriptionInstituto Grifols, S.AValid
FLEBOGAMMA 5% DIF SOLUTION FOR INFUSION5 %Solution for infusion · Intravenous use1 VialSAR 1120.70Biological · PrescriptionInstituto Grifols, S.AValid
FLEBOGAMMA 5% DIF SOLUTION FOR INFUSION5 %Solution for infusion · Intravenous use1 VialSAR 2241.40Biological · PrescriptionInstituto Grifols, S.AValid
FLEBOGAMMA 5% DIF SOLUTION FOR INFUSION5 %Solution for infusion · Intravenous use1 VialSAR 8965.60Biological · PrescriptionInstituto Grifols, S.AValid
FLEBOGAMMA 5% DIF SOLUTION FOR INFUSION5 %Solution for infusion · Intravenous use1 VialSAR 4482.80Biological · PrescriptionINSTITUTO GRIFOLSValid
GAMUNEX 10% solution for infusion10 %Solution for infusion · Intravenous, Subcutaneous1 VialSAR 1120.70Biological · PrescriptionGRIFOLS THERAPEUTICS INCValid
GAMUNEX 10% solution for infusion10 %Solution for infusion · Intravenous, Subcutaneous1 VialSAR 2241.40Biological · PrescriptionGRIFOLS THERAPEUTICS INCValid
GAMUNEX 10% solution for infusion10 %Solution for infusion · Intravenous, Subcutaneous1 VialSAR 4482.80Biological · PrescriptionGRIFOLS THERAPEUTICS INCValid
KIOVIG 100MG/ML SOLUTION FOR INFUSION100 mg/mlSolution for infusion · Intravenous use1 VialSAR 8965.60Biological · PrescriptionTakeda Manufacturing AGValid
KIOVIG 100MG/ML SOLUTION FOR INFUSION100 mg/mlSolution for infusion · Intravenous use1 VialSAR 4482.80Biological · PrescriptionTakeda Manufacturing AGValid
KIOVIG 100MG/ML SOLUTION FOR INFUSION100 mg/mlSolution for infusion · Intravenous use1 VialSAR 2241.40Biological · PrescriptionTakeda Manufacturing AGValid
KIOVIG 100MG/ML SOLUTION FOR INFUSION100 mg/mlSolution for infusion · Intravenous use1 VialSAR 1120.70Biological · PrescriptionTakeda Manufacturing AGValid
KIOVIG 100MG/ML SOLUTION FOR INFUSION100 mg/mlSolution for infusion · Intravenous use1 VialSAR 448.30Biological · PrescriptionTakeda Manufacturing AGValid
OCTAGAM 100 mg/ml solution for infusion100 mg/mlSolution · Intravenous use1 VialSAR 896.55Biological · PrescriptionOCTAPHARMAValid
OCTAGAM 100 mg/ml solution for infusion100 mg/mlSolution · Intravenous use1 VialSAR 2241.40Biological · PrescriptionOCTAPHARMAValid
OCTAGAM 100 mg/ml solution for infusion100 mg/mlSolution · Intravenous use1 VialSAR 4482.80Biological · PrescriptionOCTAPHARMAValid
OCTAGAM 100 mg/ml solution for infusion100 mg/mlSolution · Intravenous use1 VialSAR 8965.60Biological · PrescriptionOCTAPHARMAValid
OCTAGAM 1GM-20ML I.V1 gSolution · Intravenous use1 VialSAR 1120.70Biological · PrescriptionOCTAPHARMAValid
OCTAGAM 1GM-20ML I.V1 gSolution · Intravenous use1 BottleSAR 2241.40Biological · PrescriptionOCTAPHARMAValid
INTRAGLOBIN 250MG250 mgSolution for injection · Intravenous use1 VialSAR 79.55Biological · PrescriptionBIOTESTWithdrawn by MAH · Not Marketed
INTRAGLOBIN 500MG+DILUENT500 mgSolution for injection · Intravenous use1 VialSAR 159.15Biological · PrescriptionBIOTESTWithdrawn by MAH · Not Marketed
OCTAGAM 1GM-20ML I.V1 gSolution · Intravenous use1 VialSAR 448.30Biological · PrescriptionOCTAPHARMAWithdrawn by MAH · Not Marketed
OCTAGAM 1GM-20ML I.V1 gSolution · Intravenous use1 AmpouleSAR 4482.80Biological · PrescriptionOCTAPHARMAWithdrawn by MAH · Not Marketed
VIGAM LIQUID 5% I.V BOTTLE5 %Solution · Intravenous use1 BottleSAR 2241.40Biological · PrescriptionBIO-PRODUCT LABWithdrawn by MAH · Not Marketed
VIGAM LIQUID 5% I.V BOTTLE5 %Solution · Intravenous use1 BottleSAR 1120.70Biological · PrescriptionBIO-PRODUCT LABWithdrawn by MAH · Not Marketed

1 more — full table

Indications — CHI Daman Drug Formulary

ACQUIRED HEMOPHILIA; CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY; GRANULOMATOSIS WITH POLYANGIITIS AND MICROSCOPIC POLYANGIITIS; GUILLAIN-BARRE SYNDROME; MYASTHENIA GRAVIS; MYOSITIS; OPTIC NEURITIS; PEMPHIGUS; POMPE DISEASE (IOPD/LOPD); RENAL TRANSPLANT; SJOGREN'S SYNDROME

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.